Overview

Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation

Status:
Completed
Trial end date:
2019-07-30
Target enrollment:
0
Participant gender:
All
Summary
The aim of the study is to identify the role of preoperative chlorepheniramine maleate on alleviating or reducing the severity of postoperative agitation following FESS procedures.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ain Shams University
Treatments:
Chlorpheniramine
Maleic acid
Criteria
Inclusion Criteria:

- The inclusion criteria of these patients include adult patients (age 18- 60 years),
class I-II according to American society of anaesthesiologists (ASA) physical status
subjected to FESS without septoplasty.

Exclusion Criteria:

- Exclusion criteria include; patients below 18 years old or over 60 years old, patients
with ASA physical status class III-IV, morbid obesity with BMI > 30 kgm-2 at initial
hospital visit, history of neuro-psychatric ailment or chronic use of antipsychotic
drugs, severe cardiovascular disease, any coagulopathies, pregnancy, history of
relevant drug allergy, any possibility of anticipated difficult intubation.